Kymera Therapeutics (KYMR) Operating Margin Growth (1y) (2020 - 2026)
Powered by 
Analysis
Kymera Therapeutics (KYMR) Operating Margin Growth (1y) (2020 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | -143.00 |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 78.00 |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 1,135.00 |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 7,666.00 |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 1,238.00 |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 2,002.00 |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | -1,651.00 |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 29,091.00 |
| 10 | Kymera Therapeutics | 11.52 Bn | 10.83 Bn | - | 62,050.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 62,050.00 |
| Mar 31, 2026 | 9,189.00 |
| Dec 31, 2025 | -231,884.00 |
| Sep 30, 2025 | -141,943.00 |
| Jun 30, 2025 | -53,828.00 |
| Mar 31, 2025 | 22,541.00 |
| Dec 31, 2024 | -105,184.00 |
| Sep 30, 2024 | -71,158.00 |
| Jun 30, 2024 | 6,418.00 |
| Mar 31, 2024 | -8,335.00 |
| Dec 31, 2023 | 19,903.00 |
| Sep 30, 2023 | -74,643.00 |
| Jun 30, 2023 | 9,172.00 |
| Mar 31, 2023 | -9,499.00 |
| Dec 31, 2022 | -1,681.00 |
| Sep 30, 2022 | -32,910.00 |
| Jun 30, 2022 | -22,090.00 |
| Mar 31, 2022 | -31,342.00 |
| Dec 31, 2021 | -12,257.00 |
| Sep 30, 2021 | -8,520.00 |